You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:


Last Updated: January 16, 2021

DrugPatentWatch Database Preview

Cadila Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CADILA, and what generic and branded alternatives to CADILA drugs are available?

CADILA has fifty-five approved drugs.

There is one tentative approval on CADILA drugs.

Summary for Cadila
US Patents:0
Patent Litigation for Cadila: See patent lawsuits for Cadila

Drugs and US Patents for Cadila

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cadila Pharms Ltd HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 203845-001 Sep 18, 2014 AA RX No No   Start Trial   Start Trial
Cadila Pharms Ltd FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 206993-002 May 23, 2019 AB1 RX No No   Start Trial   Start Trial
Cadila Pharms Ltd RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 203844-004 Feb 13, 2017 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.